COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
Lancet Neurol
.
2020 Dec;19(12):970-971.
doi: 10.1016/S1474-4422(20)30413-0.
Authors
Srikanth Muppidi
1
,
Jeffrey T Guptill
2
,
Saiju Jacob
3
,
Yingkai Li
2
,
Maria E Farrugia
4
,
Amanda C Guidon
5
,
Jinny O Tavee
6
,
Henry Kaminski
7
,
James F Howard Jr
8
,
Gary Cutter
9
,
Heinz Wiendl
10
,
Matthew B Maas
6
,
Isabel Illa
11
,
Renato Mantegazza
12
,
Hiroyuki Murai
13
,
Kimiaki Utsugisawa
14
,
Richard J Nowak
15
;
CARE-MG Study Group
Collaborators
CARE-MG Study Group
:
Amanda C Guidon
,
Alok Tyagi
,
Ana Paula Sousa
,
Anthony A Amato
,
Ashwin Pinto
,
Bhaskar Roy
,
Caroline Carmichael
,
Dubravka Dodig
,
Georgina Burke
,
Gary R Cutter
,
Henry J Kaminski
,
Heinz Wiendl
,
Hiroyuki Murai
,
Ikjae Lee
,
Isabel Illa
,
Jeffrey Guptill
,
James F Howard Jr
,
James Caress
,
Jane Pritchard
,
Jinny O Tavee
,
John Vissing
,
Kamla Best
,
Kimiaki Utsugisawa
,
Mahtab Ramezani
,
Mathew Maas
,
Maria E Farrugia
,
Michael K Hehir
,
Michelle Kaku
,
Natalia Jiménez Esquivel
,
Paul Gallagher
,
Paul Maddison
,
Philip A Ambrose
,
Renato E Mantegazza
,
Richard J Nowak
,
Rocio Vazquez Do Campo
,
Saiju Jacob
,
Sami Saba
,
Shahriar Nafissi
,
Shannon Itoyama
,
Srikanth Muppidi
,
Stuart Viegas Viegas
,
Victoria Marshall
,
Yingkai Li Li
Affiliations
1
Department of Neurology, Stanford Medical Center, Stanford, CA 94304, USA. Electronic address:
[email protected]
.
2
Duke University School of Medicine, Duke University, Durham, NC, USA.
3
Department of Neurology and Institute of Immunology and Immunotherapy, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
4
Neurology Department, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.
5
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
6
The Ken and Ruth Davee Department of Neurology, Northwestern University, Chicago, IL, USA.
7
Department of Neurology, The George Washington University, Washington, DC, USA.
8
Department of Neurology, University of North Carolina, Chapel Hill, NC, USA.
9
Department of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
10
Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
11
Department of Neurology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
12
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
13
Neuroimmunology and Neuromuscular Diseases Unit, International University of Health and Welfare, Narita, Japan.
14
Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
15
Yale University School of Medicine, Yale University, New Haven, CT, USA.
PMID:
33212055
PMCID:
PMC7837033
DOI:
10.1016/S1474-4422(20)30413-0
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / diagnosis
COVID-19 / epidemiology*
Humans
Myasthenia Gravis / diagnosis
Myasthenia Gravis / epidemiology*
Registries*
Risk Factors
SARS-CoV-2*
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States